Original Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2013; 19(15): 2340-2347
Published online Apr 21, 2013. doi: 10.3748/wjg.v19.i15.2340
Figure 3
Figure 3 Effect of phosphorothioate antisense oligodeoxynucleotides and other reagents on telomerase activity in gastrointestinal stromal tumors tissues (n = 10 tumors per group). bP < 0.01 vs tumors treated with phosphorothioate antisense oligodeoxynucleotides (PS-ASODN) and imatinib.